Europe Capillary Blood Collection and Sampling Devices Market – Industry Trends and Forecast to 2030

 Europe Capillary Blood Collection and Sampling Devices Market Analysis and Size

The increasing number of hospital surgical procedures is driving the market for capillary blood collection and sampling devices. Blood collection products help patients undergoing chemotherapy, dialysis, organ and tissue transplantation, and complex surgeries. More people are getting regular health checks because of the rising prevalence of chronic and lifestyle diseases caused by sedentary lifestyles. As a result, the demand for capillary blood collection and sampling devices as the primary method of disease diagnosis has increased.

Data Bridge Market Research analyses that the capillary blood collection and sampling devices market, which is USD 1105.11 million in 2022, is expected to reach USD 1708.90 million by 2030, at a CAGR of 5.6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Europe Capillary Blood Collection and Sampling Devices Market Scope and Segmentation      

Market Definition

Capillary blood collection devices are used to extract capillary blood. Capillary blood can be obtained through a finger, earlobe, or heel puncture. It is also possible to make an incision in the skin. Capillary blood collection and sampling techniques have gained popularity because they extract a precise amount of blood while lowering the risk of anaemia. The volumetric micro sampling technique is now widely used for collecting capillary blood. Furthermore, new technological advancements are being made to meet the needs of doctors and patients.

Europe Capillary Blood Collection and Sampling Devices Market Dynamics

Drivers

• Rise in chronic diseases

Chronic disease is common among the elderly. According to the World Bank Group, Japan and Italy have the largest geriatric populations in 2020, accounting for 28% and 23% of the global geriatric population, respectively. Furthermore, 20% and 16% of the elderly populations in the EU and North America, respectively, were exposed to the risk of diabetes, which is expected to fuel market growth.

• The rising availability of POC diagnostics

Point-of-care testing is diagnostic testing performed at the bedside of patients in their homes. It can also be done at any time and from any location. As a result, it is also known as bedside testing. Previously, testing was limited to the laboratories to which the specimen was sent, and obtaining the sample could take anywhere from hours to days. With the advancements of this technique, doctors can now obtain lab-quality diagnostic results in minutes rather than days. It not only saves time, but it also enables clinicians to provide quality and effective patient care in the patient's home. Point-of-care diagnostics is becoming more popular because of its advantages,.

According to various reports, the total value of the global capillary blood collection and sampling devices treatment market was USD 40-45 billion, with POC diagnostics contributing USD 12-13 billion.

As health awareness and the prevalence of infectious diseases have grown, so has the demand for point-of-care testing. Traditional venous blood collection methods and arterial methods are invasive and painful with an increased risk of needle stick injuries and contamination if not carried out by trained personnel. Capillary blood collection, on the other hand, is less invasive, causes less pain, and has fewer side effects. It also does not necessitate the use of skilled professionals, making it a point care testing technique. With the rise in POC testing, capillary collection devices have advanced.

Opportunities

• Technological advancements in capillary blood collection devices

Blood collection is an important step in the delivery of healthcare. 70% to 80% of clinical decisions are made based on blood sample analysis. Various companies are using safer, easier, and more efficient methods to collect blood samples, thanks to the growing trend of blood collection innovation. For pharmacy clinics, capillary blood sampling is an excellent technique. This method is chosen over venipuncture due to its ease of use and safety; it also eliminates the need for skilled technicians. One disadvantage of finger sticks is that the blood droplets vary in size. This problem can be solved by introducing new and innovative products.

For instance TAP, the world's first device that draws blood with a push button, was introduced by Seventh Sense Bio systems. With the push of a button, this device is worn on the upper arm and draws blood. This makes high-quality lab testing more accessible and affordable.

Restraints/Challenges

•  Risks associated to the capillary blood assortment technologies

Higher risks associated with capillary blood collection technologies and the disadvantages of micro-collection of blood are expected to limit market growth during the forecast period. Capillary blood collection can occasionally cause blood cells to rupture, resulting in inaccurate results. Both methods of collection can cause bleeding and infection.

This capillary blood collection and sampling devices treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the capillary blood collection and sampling devices treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Capillary Blood Collection and Sampling Devices Treatment Market

The COVID-19 pandemic has created both challenges and opportunities in the global market.Supply chain disruptions of medical devices/equipment and essential medical supplies were common during the pandemic due to global travel and trade restrictions. The virus outbreak, on the other hand, is driving significant growth in the point-of-care (POC) testing devices segment. As the virus spread, the number of infected patients increased rapidly, necessitating increased blood collection via various safety measures for antibody testing.

Recent developments

• In 2020, B.D. and BioMedomics, a privately held clinical diagnostics company based in North Carolina, announced the development of a 15-minute at-home rapid test to assess current COVID-19 exposure. This is a novel testing device that will increase revenue generation.

Europe Capillary Blood Collection and Sampling Devices Market Scope

The capillary blood collection and sampling devices market is segmented on the basis of product, modality, mode of administration, application, platform, procedure, age group, test type, technology, material, end user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Blood Sampling Devices
• Capillary Blood Collection Devices
• Rapid Test Cassette
• Remote Capillary Blood Collection Device
• Wearable Capillary Blood Collection Device

Modality

• Manual Sampling
• Automated/Autoinjection Sampling

 Mode of Administration

• Puncture
• Incision

Application

• Cardiovascular Disease
• Infection and Infectious Disease
• Respiratory Diseases
• Cancers
• Rheumatoid Arthritis
• Others

 Platform

• Enzyme Immunoassay Platform (Elisa Platform)
• PCR Platform
• Lateral Flow Immunoassay Platform
• ELTABA Platform
• Others

Procedure

• Conventional
• Point of Care Testing

Age Group

• Geriatrics
• Infant
• Pediatric
• Adult

Test Type

• Whole Blood Test
• Dried Blood Spot Tests
• Plasma/Serum Protein Tests
• Liver Panel/Liver Profile/Liver Function Tests
• Comprehensive Metabolic Panel (CMP) Tests
• Others

 Technology

• Volumetric Absorptive Microsampling
• Capillary Electrophoresis-Based Chemical Analysis
• Others

 Material

• Plastic
• Glass
• Stainless Steel
• Ceramic

 End User

• Laboratories
• Home Care Setting

 Distribution Channel

• Direct Tender
• Retail Sales
• Others

Capillary Blood Collection and Sampling Devices Market Regional Analysis/Insights

The capillary blood collection and sampling devices market is analyzed and market size insights and trends are provided by country, product, modality, mode of administration, application, platform, procedure, age group, test type, technology, material, end user, distribution channel as referenced above.

The countries covered in the capillary blood collection and sampling devices market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

Germany is dominating in the European region for the capillary blood collection and sampling devices market Germany is investing heavily in R&D to provide better care for pregnant women and children. In addition, the manufacturers resurrected the CE market agreement for a wide range of products, allowing Germany to control capillary blood collection and sampling devices throughout Europe.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The capillary blood collection and sampling devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for capillary blood collection and sampling devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the capillary blood collection and sampling devices market. The data is available for historic period 2011-2021.

Competitive Landscape and Capillary Blood Collection and Sampling Devices Market Share Analysis

The capillary blood collection and sampling devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to capillary blood collection and sampling devices market.

Some of the major players operating in the capillary blood collection and sampling devices market are:

• B.D. (U.S.)
• Terumo BCT Inc. (U.S.)
• Fresenius KABI AG (Germany)
• Grifols S.A. (Spain)
• Nipro Medical Corporation (U.S.)
• Greiner AG (Austria)
• Quest Diagnostics Incorporated (U.S.)
• Mitra Industries Private Limited (India)
• SARSTEDT AG & Co. KG (Germany)
• CML Biotech (India)
• Macopharma (France)
• Neomedic Limited (U.S.)
• Haemonetics Corporation (U.S.)
• ICU Medical, Inc. (U.S.)
• SB-KAWASUMI LABORATORIES, INC. (Japan)
• Retractable Technologies Inc. (U.S.)

SKU-54363